Efficacy and safety of platelet-rich plasma (PRP) in the treatment of male pattern hair loss
- Conditions
- androgenic alopecia.Androgenic alopecia Incl.: male-pattern baldness
- Registration Number
- IRCT2014110919870N1
- Lead Sponsor
- Mehrashkar company
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- Not specified
Androgenetic alopecia based on a clinical diagnosis made by a dermatologist;male subjects; 18-50 years old; hair loss longer than 6 months; Hamilton-Norwood grade III-VI;Willingness to participate in the study and giving written informed consent.
Exclusion criteria:
Any topical or systemic treatment for hair loss in the past 6 months;Scalp infection
Malignant disease;Receiving chemotherapy or any immunosuppressive medication
Auto-immune disease (Hashimoto, rheumatoid arthritis, lupus, ….);Use of any growth factor containing medication;Hemoglobin level below 10, thrombocytopenia (or platelet count below 100,000);Serum albumin below 2.5 g/dl;History of vascular surgery in the past three months;Addiction to oral or intravenous narcotics;
Any systemic disease interacting with hair growth ;History of hematologic disorders;
Patient currently enrolled or previously enrolled (within last 3 months) in another clinical trial
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Increase hair density. Timepoint: after 10 weeks. Method of measurement: trichography.
- Secondary Outcome Measures
Name Time Method Increase hair thickness. Timepoint: after 10 weeks. Method of measurement: trichography.